For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
March 9, 2021

Fostering and Catalyzing Biotech Startups Out of Academia: Insights From the 2021 Weill Cornell Medicine Startup Symposium

At Weill Cornell Medicine, we think differently about supporting startups. In an effort to nucleate, foster and catalyze our startups, we recently hosted our annual Startup Symposium and InvestorConnect event. Over 200 people attended the symposium, which featured an all-star panel on how companies launching out of academia get to seed funding. Dr. Bob Langer, Institute Professor at MIT and founder of numerous biotech companies, including Moderna, was our Keynote Speaker.

October 26, 2020

University’s thriving business incubators, accelerators take off

But they soon discovered that Weill Cornell Medicine’s BioVenture eLab, a recently established hub of the institution’s entrepreneurial system, was launching its inaugural 2017 Business Plan Challenge competition. The 10-week event, designed to help Weill Cornell Medicine clinicians and researchers commercialize their concepts, would culminate with a “Shark Tank”-type contest in which teams compete for a total of $100,000 in prize money.

May 24, 2019

Biomedical Business Plan Challenge Nurtures Weill Cornell Medicine Entrepreneurs

Iris was one of seven companies formed by Weill Cornell Medicine investigators that participated in the Business Plan Challenge. The groups competed in Griffis Faculty Club in front of a panel of seven expert judges comprised of investors who specialize in early-stage companies, for investment capital for their NewCos  to help commercialize their technologies.

March 27, 2018

Du Cheng, 29

Now an M.D.-Ph.D. student, Du Cheng was initially rejected from college and later from all but one medical school. But he has since distinguished himself by balancing the rigors of studying medicine with running his own startup, iDu Optics, which has generated more than $500,000 in revenue.

March 22, 2018

The Entrepreneurs

Fostering a Culture of Innovation, Weill Cornell Medicine is Making it Faster and Easier for Researchers to Move their Discoveries From Bench to Bedside

May 26, 2017

Running the Numbers

Computational Biology Student Neel Madhukar Designs a Powerful Tool for Optimizing Drug Development.

May 23, 2017

Baby Steps

Infertility affects about 12 percent of American couples. Celmatix, a New York City-based personalized medicine company focused on reproductive health, is trying to change that.

May 5, 2017

Pioneering Program Teaches Students How to Commercialize Medical Technologies

As an undergraduate student, Du Cheng invented a laboratory camera adapter that would allow scientists to capture images with an iPhone and then view them through a microscope.

August 4, 2014

Moneyball Could Offer Winning Strategy for Drug Development

Researchers at Weill Cornell Medicine have developed a promising new AI tool that better predicts which drug candidates are likely to be too toxic—and it’s based on the Oakland A’s winning strategy, immortalized in the blockbuster book and movie Moneyball.